Amneal Pharmaceuticals
AMRX----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Amneal Pharmaceuticals(AMRX) predict that the Revenue is 722.52 M (+3.9%), Beat estimate;the EBIT is 158.82 M (+44.62%), Beat estimate;the EPS is 0.19 (+375%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.72B3.90%
0.72B3.07%
+0.01B0.83%
EBITExceed expectations
0.16B44.62%
0.14B23.31%
+0.02B21.31%
EPSExceed expectations
0.19375.00%
0.035112.38%
+0.1549387.38%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 30, 2026
Estimate Revenue770.91 M
Estimate EBIT159.15 M
Estimate EPS0.0467
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf